First Tracks Biotherapeutics
TRAX• NASDAQ
$23.64
+3.59+17.91%
In the past 24 hours
No 24-hour summary has been generated yet.
Valuation
Market Cap$696.71M
Enterprise Value$327.38M
PE (TTM)—
PE (Fwd)0.00
Price to Sales0.00
EV / EBITDA0.00
Price to Book2.10
PEG Ratio—
Cash Flow
FCF Yield—
FCF / Share-$3.63
SBC-Adj FCF Yield—
SBC-Adj FCF / Share-$4.40
SBC Impact—
Margins & Growth
Gross Margin—
Operating Margin0.00%
Profit Margin0.00%
Quarterly Rev YoY0.00%
Quarterly EPS YoY0.00%
Balance
Cash$123.08M
Debt—
Net Debt-$123.08M
Current Ratio10.78
Debt / Equity—
Dividend
Dividend Yield—
Payout Ratio—
DPS (TTM)$0.00
Last Ex-Date—
Dividend history
Cash dividends by ex-date, not an investment recommendation.
No saved cash dividend records are available for this instrument yet.
Price
+86.58%
Mar 10, 2026 - Apr 29, 2026 · 33 daily points
Quick Stats
Open
$19.82
Day High
$25.58
Day Low
$19.65
Prev Close
$20.05
Market Cap
—
Volume
707,748
First Tracks Biotherapeutics (TRAX) analysis
Wrqti brings First Tracks Biotherapeutics data into one page covering available price, financial statements, valuation ratios, margins, cash-flow metrics, news, and alerts. This page helps you understand the numbers and is not a buy or sell recommendation.
Available price
$23.64
Market cap
$696.71M
PE ratio
—
Price to book
2.10
Profit margin
0.00%
FCF yield
—
Stocks related to First Tracks Biotherapeutics
Companies in the same sector you can compare with First Tracks Biotherapeutics: